Future Journal of Pharmaceutical Sciences is affiliated with Future University in Egypt.
Optimization of simvastatin transdermal patch for hyperlipidemia treatment in rat model
Biopharmaceutics Classification System says that simvastatin (SMV) is a Class II drug with low bioavailability (5%). This is because it dissolves slowly and is broken down a lot in the first pass. Simvastatin ...